ghk cu face injection GHK-CU Before and After Pictures – Neurogan Health What is a GHK CU
Description
Mild to moderate pain Protocol: BPC-157: 250mcg twice daily Duration: 4-8 weeks Method: Injectable near pain site or systemic Expected outcome: 40-60% pain reduction Improved function May be sufficient alone Severe or chronic pain Protocol: BPC-157: 500mcg twice daily TB-500: 5-10mg weekly loading for 4-6 weeks, then 2-5mg maintenance Duration: 12-16 weeks minimum Method: Injectable Expected outcome: 50-70% pain reduction Significant functional improvement Better quality of life Multiple pain sites or systemic pain Protocol: BPC-157: 250-500mcg twice daily (systemic injections - abdomen/thighs) TB-500: 5mg weekly Optional: KPV 500mcg daily if inflammation major factor Duration: 12-24 weeks Expected outcome: 40-60% overall pain reduction Improved multiple areas Better mobility Maintenance protocol After initial relief: BPC-157: 250mcg daily OR every other day TB-500: 2-5mg weekly OR biweekly Duration: Ongoing as needed Why maintenance: Prevents pain return Continues healing Safe long-term Use our peptide dosing guide , peptide dosage chart , and how to calculate peptide dosages

41-44 For this reason, Life Extension suggests most individuals strive to keep homocysteine levels below 12 mol/L, with less than 8 mol/L being considered ideal (although the latter may be difficult for some people to attain)

Asian J Pharm Sci 2018;13(1):8290

Autocrine GH enhances cell viability, clonogenic survival, and DNA repair in breast and endometrial cancers after ionizing radiation (Wu et al., 2014), whereas the over-expression of GHR in rectal cancer is predictive factor for tumor response to preoperative radiotherapy (Wu et al., 2006)
